Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
2010 • 5,969 citations
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
1995 • 5,124 citations
CD4+CD25high Regulatory Cells in Human Peripheral Blood
2001 • 1,882 citations
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 • 1,733 citations
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
2001 • 1,659 citations
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
1975 • 1,605 citations
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
2003 • 1,252 citations
Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance
1999 • 1,223 citations
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
2005 • 1,090 citations
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.
1999 • 1,066 citations
Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells
2001 • 856 citations
CD4+CD25+ Immunoregulatory T Cells
2002 • 709 citations
IMMUNOPHARMACOLOGY OF RAPAMYCIN
1996 • 651 citations
Regulatory T cells under scrutiny
2003 • 427 citations
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.
2001 • 421 citations
The role of different subsets of T regulatory cells in controlling autoimmunity
2000 • 323 citations
Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells
2004 • 323 citations
A peripheral circulating compartment of natural naive CD4+ Tregs
2005 • 299 citations
Inhibition of Cell Cycle Progression by Rapamycin Induces T Cell Clonal Anergy Even in the Presence of Costimulation
1999 • 288 citations
RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1
2001 • 224 citations
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade
2003 • 180 citations
Mechanism of action of rapamycin: New insights into the regulation of G1-phase progression in eukaryotic cells
1995 • 166 citations
Anergic T cells act as suppressor cellsin vitro andin vivo
1999 • 144 citations
Mammalian Target of Rapamycin: A New Molecular Target for Breast Cancer
2003 • 140 citations
Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery1
2004 • 79 citations
Cited By (0)
No citing papers found in database